Suppr超能文献

钾氯共转运体KCC3作为人类食管鳞状细胞癌的独立预后因素。

The K-Cl cotransporter KCC3 as an independent prognostic factor in human esophageal squamous cell carcinoma.

作者信息

Shiozaki Atsushi, Takemoto Kenichi, Ichikawa Daisuke, Fujiwara Hitoshi, Konishi Hirotaka, Kosuga Toshiyuki, Komatsu Shuhei, Okamoto Kazuma, Kishimoto Mitsuo, Marunaka Yoshinori, Otsuji Eigo

机构信息

Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.

Department of Pathology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.

出版信息

Biomed Res Int. 2014;2014:936401. doi: 10.1155/2014/936401. Epub 2014 Jul 9.

Abstract

The objectives of the present study were to investigate the role of K-Cl cotransporter 3 (KCC3) in the regulation of cellular invasion and the clinicopathological significance of its expression in esophageal squamous cell carcinoma (ESCC). Immunohistochemical analysis performed on 70 primary tumor samples obtained from ESCC patients showed that KCC3 was primarily found in the cytoplasm of carcinoma cells. Although the expression of KCC3 in the main tumor (MT) was related to several clinicopathological features, such as the pT and pN categories, it had no prognostic impact. KCC3 expression scores were compared between the MT and cancer nest (CN), and the survival rate of patients with a CN > MT score was lower than that of patients with a CN ≤ MT score. In addition, the survival rate of patients in whom KCC3 was expressed in the invasive front of tumor was lower than that of the patients without it. Furthermore, multivariate analysis demonstrated that the expression of KCC3 in the invasive front was one of the most important independent prognostic factors. The depletion of KCC3 using siRNAs inhibited cell migration and invasion in human ESCC cell lines. These results suggest that the expression of KCC3 in ESCC may affect cellular invasion and be related to a worse prognosis in patients with ESCC.

摘要

本研究的目的是探讨钾氯共转运体3(KCC3)在调节细胞侵袭中的作用及其在食管鳞状细胞癌(ESCC)中表达的临床病理意义。对70例ESCC患者的原发性肿瘤样本进行免疫组织化学分析,结果显示KCC3主要存在于癌细胞的细胞质中。虽然KCC3在主瘤(MT)中的表达与一些临床病理特征相关,如pT和pN分类,但它对预后没有影响。比较了MT和癌巢(CN)中的KCC3表达评分,CN>MT评分患者的生存率低于CN≤MT评分的患者。此外,KCC3在肿瘤侵袭前沿表达的患者生存率低于无表达的患者。此外,多变量分析表明,KCC3在侵袭前沿的表达是最重要的独立预后因素之一。使用小干扰RNA(siRNAs)敲低KCC3可抑制人ESCC细胞系的细胞迁移和侵袭。这些结果表明,KCC3在ESCC中的表达可能影响细胞侵袭,并与ESCC患者的不良预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/4119626/cefc8b48ee2c/BMRI2014-936401.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验